236 related articles for article (PubMed ID: 35675434)
21. SRF617 Is a Potent Inhibitor of CD39 with Immunomodulatory and Antitumor Properties.
Warren MC; Matissek S; Rausch M; Panduro M; Hall RJ; Dulak A; Brennan D; Das Yekkirala S; Koseoglu S; Masia R; Yang Y; Reddy N; Prenovitz R; Strand J; Zaidi T; Devereaux E; Foissac CJ; Stagg J; Lee BH; Holland P; Palombella VJ; Lake AC
Immunohorizons; 2023 May; 7(5):366-379. PubMed ID: 37219538
[TBL] [Abstract][Full Text] [Related]
22. Dinaciclib induces immunogenic cell death and enhances anti-PD1-mediated tumor suppression.
Hossain DMS; Javaid S; Cai M; Zhang C; Sawant A; Hinton M; Sathe M; Grein J; Blumenschein W; Pinheiro EM; Chackerian A
J Clin Invest; 2018 Feb; 128(2):644-654. PubMed ID: 29337311
[TBL] [Abstract][Full Text] [Related]
23. A self-amplified ROS-responsive chemodrug-inhibitor conjugate for multi-drug resistance tumor therapy.
Sun T; Xu J; Chen T; Tu C; Zhu L; Yan D
Biomater Sci; 2022 Feb; 10(4):997-1007. PubMed ID: 35044379
[TBL] [Abstract][Full Text] [Related]
24. Cancer-cell-biomimetic Upconversion nanoparticles combining chemo-photodynamic therapy and CD73 blockade for metastatic triple-negative breast cancer.
Jin F; Qi J; Liu D; You Y; Shu G; Du Y; Wang J; Xu X; Ying X; Ji J; Du Y
J Control Release; 2021 Sep; 337():90-104. PubMed ID: 34274385
[TBL] [Abstract][Full Text] [Related]
25. Regulating the immunosuppressive tumor microenvironment to enhance breast cancer immunotherapy using pH-responsive hybrid membrane-coated nanoparticles.
Gong C; Yu X; Zhang W; Han L; Wang R; Wang Y; Gao S; Yuan Y
J Nanobiotechnology; 2021 Feb; 19(1):58. PubMed ID: 33632231
[TBL] [Abstract][Full Text] [Related]
26. Near-infrared light triggered drug delivery system for higher efficacy of combined chemo-photothermal treatment.
Chen Y; Li H; Deng Y; Sun H; Ke X; Ci T
Acta Biomater; 2017 Mar; 51():374-392. PubMed ID: 28088668
[TBL] [Abstract][Full Text] [Related]
27. Improving combination therapies: targeting A2B-adenosine receptor to modulate metabolic tumor microenvironment and immunosuppression.
Evans JV; Suman S; Goruganthu MUL; Tchekneva EE; Guan S; Arasada RR; Antonucci A; Piao L; Ilgisonis I; Bobko AA; Driesschaert B; Uzhachenko RV; Hoyd R; Samouilov A; Amann J; Wu R; Wei L; Pallerla A; Ryzhov SV; Feoktistov I; Park KP; Kikuchi T; Castro J; Ivanova AV; Kanagasabai T; Owen DH; Spakowicz DJ; Zweier JL; Carbone DP; Novitskiy SV; Khramtsov VV; Shanker A; Dikov MM
J Natl Cancer Inst; 2023 Nov; 115(11):1404-1419. PubMed ID: 37195421
[TBL] [Abstract][Full Text] [Related]
28. Nanozyme-Based Enhanced Cancer Immunotherapy.
Phan NM; Nguyen TL; Kim J
Tissue Eng Regen Med; 2022 Apr; 19(2):237-252. PubMed ID: 35099759
[TBL] [Abstract][Full Text] [Related]
29. TME-activatable theranostic nanoplatform with ATP burning capability for tumor sensitization and synergistic therapy.
Luo Y; Qiao B; Zhang P; Yang C; Cao J; Yuan X; Ran H; Wang Z; Hao L; Cao Y; Ren J; Zhou Z
Theranostics; 2020; 10(15):6987-7001. PubMed ID: 32550917
[TBL] [Abstract][Full Text] [Related]
30. High-Throughput Screening Assays for Cancer Immunotherapy Targets: Ectonucleotidases CD39 and CD73.
Kumar M; Lowery R; Kumar V
SLAS Discov; 2020 Mar; 25(3):320-326. PubMed ID: 31868071
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity.
Bastid J; Regairaz A; Bonnefoy N; Déjou C; Giustiniani J; Laheurte C; Cochaud S; Laprevotte E; Funck-Brentano E; Hemon P; Gros L; Bec N; Larroque C; Alberici G; Bensussan A; Eliaou JF
Cancer Immunol Res; 2015 Mar; 3(3):254-65. PubMed ID: 25403716
[TBL] [Abstract][Full Text] [Related]
32. Amplification of spatially isolated adenosine pathway by tumor-macrophage interaction induces anti-PD1 resistance in hepatocellular carcinoma.
Lu JC; Zhang PF; Huang XY; Guo XJ; Gao C; Zeng HY; Zheng YM; Wang SW; Cai JB; Sun QM; Shi YH; Zhou J; Ke AW; Shi GM; Fan J
J Hematol Oncol; 2021 Nov; 14(1):200. PubMed ID: 34838121
[TBL] [Abstract][Full Text] [Related]
33. A
Kjaergaard J; Hatfield S; Jones G; Ohta A; Sitkovsky M
J Immunol; 2018 Jul; 201(2):782-791. PubMed ID: 29802128
[TBL] [Abstract][Full Text] [Related]
34. Chemo-Photothermal Combination Cancer Therapy with ROS Scavenging, Extracellular Matrix Depletion, and Tumor Immune Activation by Telmisartan and Diselenide-Paclitaxel Prodrug Loaded Nanoparticles.
Fang T; Zhang J; Zuo T; Wu G; Xu Y; Yang Y; Yang J; Shen Q
ACS Appl Mater Interfaces; 2020 Jul; 12(28):31292-31308. PubMed ID: 32551473
[TBL] [Abstract][Full Text] [Related]
35. Targeting adenosine and regulatory T cells in cancer immunotherapy.
Churov A; Zhulai G
Hum Immunol; 2021 Apr; 82(4):270-278. PubMed ID: 33610376
[TBL] [Abstract][Full Text] [Related]
36. Near-infrared light triggered activation of pro-drug combination cancer therapy and induction of immunogenic cell death.
Kang X; Cai Y; Wang Q; Wang C; Chen W; Yang W; Suryawanshi A; Zhou G; Chen P; Li F
Int J Pharm; 2021 Sep; 607():120972. PubMed ID: 34363916
[TBL] [Abstract][Full Text] [Related]
37. Preventing ATP Degradation by ASO-Mediated Knockdown of CD39 and CD73 Results in A2aR-Independent Rescue of T Cell Proliferation.
Festag J; Thelemann T; Schell M; Raith S; Michel S; Jaschinski F; Klar R
Mol Ther Nucleic Acids; 2020 Sep; 21():656-669. PubMed ID: 32739778
[TBL] [Abstract][Full Text] [Related]
38. Production of adenosine by ectonucleotidases: a key factor in tumor immunoescape.
Ghiringhelli F; Bruchard M; Chalmin F; Rébé C
J Biomed Biotechnol; 2012; 2012():473712. PubMed ID: 23133312
[TBL] [Abstract][Full Text] [Related]
39. Next steps for clinical translation of adenosine pathway inhibition in cancer immunotherapy.
Augustin RC; Leone RD; Naing A; Fong L; Bao R; Luke JJ
J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35135866
[TBL] [Abstract][Full Text] [Related]
40. Binary Cooperative Prodrug Nanoparticles Improve Immunotherapy by Synergistically Modulating Immune Tumor Microenvironment.
Feng B; Zhou F; Hou B; Wang D; Wang T; Fu Y; Ma Y; Yu H; Li Y
Adv Mater; 2018 Sep; 30(38):e1803001. PubMed ID: 30063262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
